Paul Burgess

Chief Business Development and Strategic Operations Officer

Paul Burgess is Cerevel’s Chief Business Development and Strategic Operations Officer.

Prior to joining Cerevel, Mr. Burgess was the chief operating officer and chief legal officer of Translate Bio. At Translate Bio, he led business development, legal, program management, quality, technical operations and partner collaborations. Mr. Burgess joined Translate Bio in 2015 and remained until 2021, when the company was sold to Sanofi for $3.2 billion.

Paul Burgess is a biotechnology executive with over 20 years of experience working at both start-up companies and larger pharmaceutical organizations. Prior to Translate Bio, Mr. Burgess worked in a legal role at a number of companies including Scholar Rock, Civitas Therapeutics, BIND Therapeutics and Transform Pharmaceuticals. Mr. Burgess also previously worked in the lab at Genetics Institute.

Mr. Burgess earned his B.S. from Merrimack College and an M.S. in Pharmacology from Northeastern University. He also received his J.D. from Northeastern University School of Law.